Maternal caffeine consumption during pregnancy and risk of low birth weight: A dose-response meta-analysis of observational studies

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Rhee, Jongeun ^a   Kim, Rockli ^a   Kim, Yongjoo ^a   Tam, Melanie ^a   Lai, Yizhen ^a   Keum, NaNa ^a   Oldenburg, Catherine Elizabeth ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYTOCHROME P450 1A2; COFFEE;

ARTICLE; COFFEE; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME INHIBITION; HIGH RISK INFANT; HUMAN; INCIDENCE; LOW BIRTH WEIGHT; MATERNAL NUTRITION; NUCLEOTIDE METABOLISM; PREGNANCY; PRENATAL EXPOSURE; PROTEIN FUNCTION; RISK ASSESSMENT; SMOKING; TEA; ADVERSE EFFECTS; BIRTH WEIGHT; DRUG EFFECTS; FEMALE; META ANALYSIS; NEWBORN;

BIRTH WEIGHT; CAFFEINE; COFFEE; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; PREGNANCY;

EID: 84941281191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132334     Document Type: Article

References (49)

1. JE G. Food and Drug Administration, news release No. P80-36. Washington, DC: FDA, September 4, 1980.
2. Gynecologists ACoOa. Moderate Caffeine Consumption During Pregnancy. https://wwwacogorg/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Moderate-Caffeine-Consumption-During-Pregnancy. 2010.
3. Knutti R, Rothweiler H, Schlatter C. Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol. 1981; 21(2):121-6. Epub 1981/01/01. PMID: 7341280.
4. Soyka LF. Caffeine ingestion during pregnancy: in utero exposure and possible effects. Semin Perinatol. 1981; 5(4):305-9. Epub 1981/10/01. PMID: 7302603.
5. Goldstein A, Warren R. Passage of caffeine into human gonadal and fetal tissue. Biochem Pharmacol. 1962; 11:166-8. Epub 1962/02/01. PMID: 13899873.
6. Bakker R, Steegers EA, Obradov A, Raat H, Hofman A, Jaddoe VW. Maternal caffeine intake from coffee and tea, fetal growth, and the risks of adverse birth outcomes: The Generation R Study. Am J Clin Nutr. 2010; 91(6):1691-8. Epub 2010/04/30. doi:10.3945/ajcn.2009.28792 PMID: 20427730.
7. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Ascherio AL, Stampfer MJ. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation. 1996; 94(12):3246-50. Epub 1996/12/15. PMID: 8989136.
8. Larroque B, Kaminski M, Lelong N, Subtil D, Dehaene P. Effects of birth weight of alcohol and caffeine consumption during pregnancy. Am J Epidemiol. 1993; 137(9):941-50. Epub 1993/05/01. PMID: 8317451.
9. Fortier I, Marcoux S, Beaulac-Baillargeon L. Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. Am J Epidemiol. 1993; 137(9):931-40. Epub 1993/05/01. PMID: 8317450.
10. Fernandes O, Sabharwal M, Smiley T, Pastuszak A, Koren G, Einarson T. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: A meta-analysis. Reprod Toxicol. 1998; 12(4):435-44. Epub 1998/08/26. PMID: 9717693.
11. Greenwood DC, Thatcher NJ, Ye J, Garrard L, Keogh G, King LG, et al. Caffeine intake during pregnancy and adverse birth outcomes: A systematic review and dose-response meta-analysis. Eur J Epidemiol. 2014. Epub 2014/09/03. doi:10.1007/s10654-014-9944-x PMID: 25179792.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15):2008-12. Epub 2000/05/02. PMID: 10789670.
13. Eskenazi B, Stapleton AL, Kharrazi M, Chee WY. Associations between maternal decaffeinated and caffeinated coffee consumption and fetal growth and gestational duration. Epidemiology. 1999; 10 (3):242-9. Epub 1999/05/07. PMID: 10230832.
14. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med. 1982; 306(3):141-5. Epub 1982/01/21. doi:10.1056/NEJM198201213060304 PMID: 7054656.
15. Mills JL, Holmes LB, Aarons JH, Simpson JL, Brown ZA, Jovanovic-Peterson LG, et al. Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation. JAMA. 1993; 269 (5):593-7. Epub 1993/02/03. PMID: 8421363.
16. Bracken MB, Triche EW, Belanger K, Hellenbrand K, Leaderer BP. Association of maternal caffeine consumption with decrements in fetal growth. Am J Epidemiol. 2003; 157(5):456-66. Epub 2003/03/05. PMID: 12615610.
17. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992; 135(11):1301-9. Epub 1992/06/01. PMID: 1626547.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. Epub 1997/10/06. PMID: 9310563; PubMed Central PMCID: PMC2127453.
19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21 (11):1539-58. Epub 2002/07/12. doi:10.1002/sim.1186 PMID: 12111919.
20. Martin TR, Bracken MB. The association between low birth weight and caffeine consumption during pregnancy. Am J Epidemiol. 1987; 126(5):813-21. Epub 1987/11/01. PMID: 3661529.
21. McDonald AD, Armstrong BG, Sloan M. Cigarette, alcohol, and coffee consumption and prematurity. Am J Public Health. 1992; 82(1):87-90. Epub 1992/01/01. PMID: 1536341; PubMed Central PMCID: PMC1694404.
22. Olsen J, Overvad K, Frische G. Coffee consumption, birthweight, and reproductive failures. Epidemiology. 1991; 2(5):370-4. Epub 1991/09/01. PMID: 1742388.
23. Caan BJ, Goldhaber MK. Caffeinated beverages and low birthweight: A case-control study. Am J Public Health. 1989; 79(9):1299-300. Epub 1989/09/01. PMID: 2764212; PubMed Central PMCID: PMC1349709.
24. Fenster L, Eskenazi B, Windham GC, Swan SH. Caffeine consumption during pregnancy and fetal growth. Am J Public Health. 1991; 81(4):458-61. Epub 1991/04/01. PMID: 2003624; PubMed Central PMCID: PMC1405033.
25. Santos IS, Victora CG, Huttly S, Carvalhal JB. Caffeine intake and low birth weight: A population-based case-control study. Am J Epidemiol. 1998; 147(7):620-7. Epub 1998/04/29. PMID: 9554600.
26. Sultan Azzeh F. Risk factors associated with delivering low birth weight infants among pregnant women: A preliminary study in Western Saudi Arabia. Journal of Biological Sciences. 2013; 13(5):417- 21.
27. Jaddoe VW, Troe EJ, Hofman A, Mackenbach JP, Moll HA, Steegers EA, et al. Active and passive maternal smoking during pregnancy and the risks of low birthweight and preterm birth: The Generation R Study. Paediatr Perinat Epidemiol. 2008; 22(2):162-71. Epub 2008/02/27. doi:10.1111/j.1365-3016.2007.00916.x PMID: 18298691.
28. Horta BL, Victora CG, Menezes AM, Halpern R, Barros FC. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol. 1997; 11 (2):140-51. Epub 1997/04/01. PMID: 9131707.
29. Windham GC, Hopkins B, Fenster L, Swan SH. Prenatal active or passive tobacco smoke exposure and the risk of preterm delivery or low birth weight. Epidemiology. 2000; 11(4):427-33. Epub 2000/06/30. PMID: 10874550.
30. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol. 2000; 5(3):231-41. Epub 2000/08/24. doi:10.1053/siny.2000.0025 PMID: 10956448.
31. Salmasi G, Grady R, Jones J, McDonald SD. Environmental tobacco smoke exposure and perinatal outcomes: A systematic review and meta-analyses. Acta Obstet Gynecol Scand. 2010; 89(4):423-41. Epub 2010/01/21. doi:10.3109/00016340903505748 PMID: 20085532.
32. Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008; 93(5):F351-61. Epub 2008/01/26. doi:10.1136/adc.2007.133553 PMID: 18218658.
33. Sengpiel V, Elind E, Bacelis J, Nilsson S, Grove J, Myhre R, et al. Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Med. 2013; 11:42. Epub 2013/02/21. doi:10.1186/1741-7015-11-42 PMID: 23421532; PubMed Central PMCID: PMC3606471.
34. Balat O, Balat A, Ugur MG, Pence S. The effect of smoking and caffeine on the fetus and placenta in pregnancy. Clin Exp Obstet Gynecol. 2003; 30(1):57-9. Epub 2003/05/07. PMID: 12731747.
35. Xue F, Willett WC, Rosner BA, Forman MR, Michels KB. Parental characteristics as predictors of birthweight. Hum Reprod. 2008; 23(1):168-77. Epub 2007/10/16. doi:10.1093/humrep/dem316 PMID: 17934185.
36. Jarosz M, Wierzejska R, Siuba M. Maternal caffeine intake and its effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2012; 160(2):156-60. Epub 2011/12/07. doi:10.1016/j.ejogrb.2011.11.021 PMID: 22142815.
37. Clausson B, Granath F, Ekbom A, Lundgren S, Nordmark A, Signorello LB, et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol. 2002; 155(5):429-36. Epub 2002/02/28. PMID: 11867354.
38. Aldridge A, Bailey J, Neims AH. The disposition of caffeine during and after pregnancy. Semin Perinatol. 1981; 5(4):310-4. Epub 1981/10/01. PMID: 7302604.
39. Tassaneeyakul W, Birkett DJ, McManus ME, Veronese ME, Andersson T, Tukey RH, et al. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Biochem Pharmacol. 1994; 47(10):1767-76. Epub 1994/05/18. PMID: 8204093.
40. Tsutsumi K, Kotegawa T, Matsuki S, Tanaka Y, Ishii Y, Kodama Y, et al. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activities in humans. Clin Pharmacol Ther. 2001; 70(2):121-5. Epub 2001/08/15. doi:10.1067/mcp.2001.116495 PMID: 11503005.
41. Infante-Rivard C. Caffeine intake and small-for-gestational-age birth: modifying effects of xenobioticmetabolising genes and smoking. Paediatr Perinat Epidemiol. 2007; 21(4):300-9. Epub 2007/06/15. doi:10.1111/j.1365-3016.2007.00825.x PMID: 17564586.
42. Brent RL, Christian MS, Diener RM. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol. 2011; 92(2):152-87. Epub 2011/03/04. doi:10.1002/bdrb.20288 PMID: 21370398; PubMed Central PMCID: PMC3121964.
43. Aldridge A, Aranda JV, Neims AH. Caffeine metabolism in the newborn. Clin Pharmacol Ther. 1979; 25 (4):447-53. Epub 1979/04/01. PMID: 428190.
44. Daly JW. Alkylxanthines as research tools. J Auton Nerv Syst. 2000; 81(1-3):44-52. Epub 2000/06/28. PMID: 10869699.
45. Momoi N, Tinney JP, Keller BB, Tobita K. Maternal hypoxia and caffeine exposure depress fetal cardiovascular function during primary organogenesis. J Obstet Gynaecol Res. 2012; 38(12):1343-51. Epub 2012/05/23. doi:10.1111/j.1447-0756.2012.01880.x PMID: 22612345; PubMed Central PMCID: PMC3427416.
46. Bistoletti P, Fredholm BB, Lagercrantz H. Cyclic 3', 5'-adenosine monophosphate in umbilical cord blood of the newborn infant: relation to fetal stress and plasma catecholamines. Biol Neonate. 1981; 40 (3-4):145-9. Epub 1981/01/01. PMID: 6269661.
47. Maslova E, Bhattacharya S, Lin SW, Michels KB. Caffeine consumption during pregnancy and risk of preterm birth: A meta-analysis. Am J Clin Nutr. 2010; 92(5):1120-32. Epub 2010/09/17. doi:10.3945/ajcn.2010.29789 PMID: 20844077; PubMed Central PMCID: PMC2954446.
48. Golding J. Reproduction and caffeine consumption-a literature review. Early Hum Dev. 1995; 43 (1):1-14. Epub 1995/08/30. PMID: 8575347.
49. Chen LW, Wu Y, Neelakantan N, Chong M, Pan A, vanDam RM. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: A systematic review and dose inverted question markresponse meta-analysis. BMC Med. 2014; 12(1):174. Epub 2014/09/23. doi:10.1186/s12916-014-0174-6 PMID: 25238871; PubMed Central PMCID: PMC4198801.